Stay updated on Effect of Oral AT1001 in Fabry Disease Clinical Trial
Sign up to get notified when there's something new on the Effect of Oral AT1001 in Fabry Disease Clinical Trial page.

Latest updates to the Effect of Oral AT1001 in Fabry Disease Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded a comprehensive Locations section listing participating sites across multiple states and Quebec and updated the page revision to v3.3.3.SummaryDifference1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page shows a version update from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check37 days agoChange DetectedThe Publications section wording was updated to indicate that PubMed publications are automatically filled and may not all be about the study, and the revision label was updated to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedThe banner about government funding and operating status was removed from the page.SummaryDifference0.3%

- Check58 days agoChange DetectedMinor layout and formatting tweaks observed on the page; core study details, locations, eligibility criteria, and primary outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check87 days agoChange DetectedAdded a government operations notice and new version v3.2.0; removed older MedlinePlus topics and Revision: v3.0.2. Overall, minimal impact beyond operational status and version update.SummaryDifference3%

Stay in the know with updates to Effect of Oral AT1001 in Fabry Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effect of Oral AT1001 in Fabry Disease Clinical Trial page.